PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
Corporate Actions

Kilitch Drugs (India) Limited

In PositoAI's records, Kilitch Drugs (India) Limited has had 1 bonus issue since 2016; 1 rights issue since 2016.

Records start: dividends 2021, bonus and rights issues 2016, splits and buybacks 2022, mergers and demergers 2025. Earlier actions are not shown.

Kilitch Drugs (India) Limited Bonus History#

Ex-dateDetailsRecord dateAnnounced
24 Mar 20261:1 (1 new share for every 1 held)24 Mar 202618 Mar 2026

Kilitch Drugs (India) Limited Rights Issue History#

Ex-dateDetailsRecord dateAnnounced
15 Jul 20252:2315 Jul 20259 Jul 2025

Questions

Has Kilitch Drugs (India) Limited issued bonus shares?

Yes, 1 time in PositoAI's records (from 2016); the latest was 1:1 (1 new share for every 1 held) with ex-date 24 March 2026.

What is an ex-date and a record date?

To receive a dividend, bonus or other benefit, you must own the shares before the ex-date. The record date is the day the company checks its list of shareholders.

Records: dividends from 2021, bonus issues and rights issues from 2016, splits and buybacks from 2022, mergers and demergers from 2025; new actions are added every day. Amounts are per share in rupees. To receive a dividend or bonus, shares must be held before the ex-date. Please confirm dates with the company's own announcement. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.